XTalks
AUGUST 30, 2022
A major obstacle for CNS drug developers is the inability to target therapies to the CNS broadly (for instance, a therapy that is orally bioavailable as a pill and has difficulty crossing the blood-brain barrier) and certain CNS regions more specifically. All facilities (such as lab, pharmacy, MRI, etc.) The patients are waiting!
Pharmaceutical Technology
MARCH 21, 2023
The team required narrow nanoparticle size distribution with a short processing time and a stable low temperature milling profile.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 14, 2023
Challenges for micronization Micronization has become an increasingly significant process in the pharmaceutical industry and is necessary to produce APIs with better solubility and improved bioavailability. A number of high-impact milling methods, including ball, hammer, pin, and disc mills, have been adopted to meet this need.
The Pharma Data
MAY 16, 2021
and could change how “bioavailable” the all-important EBM triggering nutrients are. Bioavailable is a word that scientists use to describe how easy it is for your body to use a nutrient…. Now imagine that instead of having to hang your head in shame at the pharmacy…. Or explain your embarrassing symptoms to your urologist….
Pharmaceutical Technology
MARCH 7, 2023
The team required narrow nanoparticle size distribution with a short processing time and a stable low temperature milling profile.
Pharmaceutical Technology
APRIL 12, 2023
The team required narrow nanoparticle size distribution with a short processing time and a stable low temperature milling profile.
Pharmaceutical Technology
DECEMBER 19, 2022
The paper concludes by noting that the potential cost reductions generated in the production of highly bioavailable APIs, as well as improved quality control, can ultimately promote production of custom formulations. Full details of the research by Fribourg University, including methods, results, and discussion, can be found here.
Expert insights. Personalized for you.
83 
Let's personalize your content